CAS No. |
51110-01-1 |
|---|---|
中文名称 |
22-((1H-吲哚-3-基)甲基)-31-(2-氨基-2-氧代乙基)-19,34-双(4-氨基丁基)-37-(2-(2-氨基丙酰胺基)乙酰胺基)-13,25,28-三苄基-10,16-双(1-羟基乙基)-7-(羟甲基)-6,9,12,15,18,21,24,27,30,33,36-十一氧代-1,2-二硫杂-5,8,11,14,17,20,23,26,29,32,35-十一氮杂环辛三十八烷-4-羧酸 |
英文名称 |
22-((1H-indol-3-yl)methyl)-31-(2-amino-2-oxoethyl)-19,34-bis(4-aminobutyl)-37-(2-(2-aminopropanamido)acetamido)-13,25,28-tribenzyl-10,16-bis(1-hydroxyethyl)-7-(hydroxymethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontane-4-carboxylic acid |
别名 |
AGCKNFFWKTFTSC (modifications: Disulfide bridge between 3 - 14) | AKOS015896026 | BCA11001 | SCHEMBL3046327 | SOMATOSTATIN | Stilamin | AGCKNFFWKTFTSC | Somatostain Acetate | FT-0630640 | L000577 | Panhibin | Somatostatin 14 | NHXLMOGPVYXJNR-UHFFFAOYSA-N |
标准英文名 |
22-((1H-indol-3-yl)methyl)-31-(2-amino-2-oxoethyl)-19,34-bis(4-aminobutyl)-37-(2-(2-aminopropanamido)acetamido)-13,25,28-tribenzyl-10,16-bis(1-hydroxyethyl)-7-(hydroxymethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecaazacyclooctatriacontane-4-carboxylic acid |
MDL No. |
MFCD00076762 |
分子式 |
C76H104N18O19S2 |
分子量 |
1637.91 |
精确分子量 |
1636.72 |
SMILES |
CC(N)C(=O)NCC(=O)NC1CSSCC(C(=O)O)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(C(C)O)NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C23)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC1=O |
标准SMILES |
CC(O)C1NC(=O)C(CCCCN)NC(=O)C(CC2=CNC3=CC=CC=C23)NC(=O)C(CC2C=CC=CC=2)NC(=O)C(CC2C=CC=CC=2)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC(=O)C(CSSCC(NC(=O)C(CO)NC(=O)C(NC(=O)C(CC2C=CC=CC=2)NC1=O)C(C)O)C(O)=O)NC(=O)CNC(=O)C(C)N |
用途 |
Treatment of severe acute esophageal variceal bleeding; treatment of severe acute gastric or duodenal ulcer bleeding, or bleeding associated with acute erosive or hemorrhagic gastritis; prevention and treatment of acute pancreatitis and postoperative complications of pancreatic surgery; adjunctive therapy for pancreatic, biliary, and enteric fistulas; adjunctive treatment of diabetic ketoacidosis; management of acromegaly, gastrinoma, insulinoma, and vasoactive intestinal peptide-secreting tumors (VIPomas). |
InChIKey |
NHXLMOGPVYXJNR-UHFFFAOYSA-N |
|
|
评论 |
|---|